Health Committee in 2018

Meetings

Jan. 31
Feb. 5
Feb. 7
Feb. 12
Feb. 12
Feb. 14
Feb. 26
Feb. 26
Feb. 28
March 19
March 21
March 26
March 28
April 16
April 18
April 23
April 25
April 30
May 7
May 9
May 9
May 23
May 28
June 7
June 13
Sept. 20
Sept. 27
Oct. 2
Oct. 4
Oct. 16
Oct. 18
Oct. 23
Oct. 25
Oct. 30
Nov. 1
Nov. 6
Nov. 8
Nov. 20
Nov. 22
Nov. 27
Nov. 29
Dec. 4
Dec. 6
Dec. 11

Studies

Development of a National Pharmacare Program
Antimicrobial Resistance
Canada’s Food Guide
Bill S-5
Bill C-326
Bill S-228
Pre-Mixed Drinks Combining High Alcohol, Caffeine, and Sugar Content
Organ Donation
Diabetes Strategies in Canada and Abroad
Main Estimates 2018-19: Votes 1 and 5 under Canadian Food Inspection Agency, Votes 1 and 5 under Canadian Institutes of Health Research, Votes 1, 5 and 10 under Department of Health, Vote 1 under Patented Medicine Prices Review Board and Votes 1, 5 and 10 under Public Health Agency of Canada
Federally Funded Health Research (M-132)
Barriers to access to treatment and drugs for Canadians affected by Rare Diseases and Disorders
Bill C-316
Impacts of Methamphetamine Abuse in Canada
Subject Matter of Supplementary Estimates (A), 2018-19: Votes 1a and 5a under Canadian Food Inspection Agency, Vote 5a under Canadian Institutes of Health Research, Votes 1a and 10a under Department of Health, Vote 1a under Patented Medicine Prices Review Board and Vote 1a and 10a under Public Health Agency of Canada